Urgent

Type 4 renal tubular acidosis (hyperkalaemic)

Acid-Base · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Hypoaldosteronism or aldosterone resistance causing a normal anion-gap metabolic acidosis with hyperkalaemia; commonly in diabetic nephropathy and with certain drugs.

Red flags

  • Hyperkalaemia with ECG changes
  • Significant acidosis
  • Coexisting AKI
  • Cardiac arrhythmia

Assessment

Differential diagnosis

  • Type 1/2 RTA
  • CKD hyperkalaemia
  • Adrenal insufficiency
  • Drug-induced hyperkalaemia
  • Pseudohypoaldosteronism

Investigations

  • U&E, potassium, bicarbonate, chloride, VBG
  • Urine pH (usually <5.5) and urine electrolytes
  • Glucose/HbA1c (diabetes)
  • Review medications (ACEi/ARB, spironolactone, NSAIDs, trimethoprim)

Management

  • Confirm hyperkalaemic normal anion gap acidosis
  • Treat significant hyperkalaemia acutely
  • Stop or reduce culprit drugs (ACEi/ARB, potassium-sparing diuretics, NSAIDs)
  • Low-potassium diet and loop diuretic to promote kaliuresis
  • Fludrocortisone in selected hypoaldosterone patients
  • Sodium bicarbonate for persistent acidosis

Drugs & doses

Acute hyperkalaemia treatment as needed
Loop diuretic (promotes potassium loss)
Fludrocortisone (selected cases)
Sodium bicarbonate for acidosis
Stop offending drugs

Disposition

Admit if hyperkalaemia significant; nephrology follow-up.

Complications & pitfalls

  • Life-threatening hyperkalaemia
  • Arrhythmia
  • Progressive CKD

Exam pearls

  • Unlike other RTAs, this one causes hyperkalaemia
  • Very common in diabetic nephropathy
  • Drug review often resolves the problem

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.